Chem32’s founders divest to PQ Corporation for $44m

Matt Dixon • Mar 22, 2021

CCD Partners is pleased to announce the acquisition by PQ Corporation of Chem32, a founder-led supplier of catalyst pre-activation services in the US.

The deal provides an exit path for the founder-owners and a bright future for the Chem32 business.


About Chem32

Chem32 is a leading supplier of catalyst pre-activation services used in the production of traditional and renewable fuels Chem32 has patented technology and offers its services throughout the North American market.

About PQ Corporation

PQ Corporation is a leading integrated and innovative global provider of specialty catalysts, chemicals and services. 


PQ Corporation operates a network of manufacturing facilities across three specialty businesses: Refining Services provides sulfuric acid recycling to the North American refining industry; Catalysts serves the packaging and engineering plastics and the global refining, petrochemical and emissions control industries; and Performance Chemicals supplies diverse product end uses, including personal and industrial cleaning products, fuel efficient tires, surface coatings, and food and beverage products.

CCD Partners’ role

Glenn McGuire, senior advisor to CCD Partners, advised Chem32’s founders on their strategic options and positioning of the company to potential buyers including facilitating the introduction of PQ Corporation to Chem32.


Soren Marklund, Founder of Chem32, commented:


“Glenn McGuire used his experience in the catalyst industry to present Chem32 to a select group of potential buyers. His successful introduction led to a match with PQ Corporation which plans to make Chem32 grow as part of their large and successful refinery services business, offering our employees new and better opportunities.”



Glenn McGuire, Senior M&A Advisor, commented:

“We were engaged to find an exit path for the founder-owners of Chem32 and engage potential buyers. I’m pleased to say we were able to introduce several parties with strong strategic rationales and the founders’ decision to choose PQ Corporation as the new home for Chem32 has ensured a bright future for the business.”

Kurt Bitting, President of PQ’s Refining Services, commented:


“We are very excited to welcome the Chem32 team. Chem32 diversifies our service offerings while giving us exposure to the rapidly growing renewable fuels industry.”


CCD Partners is a consultancy specialised in corporate transformations in small and mid-market chemicals and life sciences businesses.

To organise a call with one of our partners please email contact@ccdpartners.com

Receive M&A news relevant to your business

At critical moments our clients engage us to provide pre-publicity "off-market" intelligence to give them the edge over the competition - we also provide up-to-the-minute public or "on-market" intelligence for free

Contact Us

We're committed to your privacy. CCD Partners uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe at any time. For more information, please see our Privacy Policy.   

RECENT POSTS

By Matt Dixon 05 Dec, 2022
Market leading provider of formulated chemical process aids and foam control, PennWhite has been acquired by Manali Petrochemicals, part of the AM International Holdings group.
By Matt Dixon 02 Dec, 2022
Global source of industrial gas news, views, and debate, gas world has been sold by John and Karen Raquet to the senior management team in an MBO, backed by Mobeus Equity Partners.
By Matt Dixon 13 Sep, 2022
Polyblend UK Ltd is one of the market leaders in PVC based polymers. We are experts in manufacturing a comprehensive range of liquid plastisol and dispersion systems, complemented by our Speciality Distribution business supplying plasticisers, resins and PVC additives.
By Matt Dixon 05 May, 2022
GFBiochemicals is a sustainable chemicals company that produces levulinic acid derivatives at commercial scale directly from biomass. Having perfected its technology, product, and certification, the company is entering a new phase of commercialization.
By CCD Partners 20 Apr, 2022
In the latest episode of the Chemical Transformations podcast , CCD Partners' Managing Partner Matt Dixon speaks with Ted Clark, former President and CEO of Royal Adhesives & Sealants, discussing his new book "Shipping Clerk to CEO: The Power of Curiosity, Will, and Self Directed Learning”. The book tells the story of Clark’s remarkable career journey from entry-level worker to CEO of a $240m chemical company by the age of 42.
By Matt Dixon 04 Feb, 2022
Esteve Química purchases one of the UQUIFA Group's two pharmaceutical fine chemicals plants in Barcelona.
By Matt Dixon 04 Feb, 2022
Specialty materials manufacturer Vertellus has acquired Polyscope Polymers B.V., a global leader in specialty additives for coatings, electronics applications, and engineering polymers.
By Matt Dixon 01 Nov, 2021
Biosynth Carbosynth is a fully hybrid Research Products, Life Sciences Reagents and Custom Synthesis and Manufacturing Services Company with global research, manufacturing and distribution facilities. They are the supplier of choice for many in the pharmaceutical, life science, food, agrochemical, cosmetic and diagnostic sectors and manufacture and source a vast range of chemical and biochemical products.
By CCD Partners 12 Oct, 2021
Steve Allin co-founded Charnwood Molecular with Phil Page in 1998. 22 years later, the business has evolved dramatically from its origins as a spinout of Loughborough University. Backed by a partnership with Synova Capital, the company is now preparing to move into a former AstraZeneca research facility and has already completed its first M&A deal, acquiring Aurelia Bioscience in summer 2021. CCD Partners’ Matt Dixon spoke with Steve about the journey from full-time academia to running a high-growth market leader.
By Matt Dixon 24 Sep, 2021
Aspire was founded in 2009. Aspire has an asset-light business model that focuses on R&D, business development and sales and marketing, while outsourcing manufacturing and distribution to specialist third parties. For more details see www.aspirepharma.co.uk.
Show More
Share by: